CSF-1R kinase inhibitors (Janssen pharmaceutical)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCSF-1R kinase inhibitors (Janssen pharmaceutical)
Drug Alias Nameoral CSF-1R inhibitor (J&J)colony stimulating factor-1 receptor inhibitor (J&J)JNJ-28337660JNJ-27301937
ClassificationSmall molecules
Mechanisms of ActionMacrophage Colony Stimulating Factor 1 inhibitorsAnticancer protein kinase inhibitors
TargetsMacrophage Colony Stimulating Factor 1
Therapy Area/IndicationsArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A